Your browser doesn't support javascript.
loading
Solubilization and refolding of variety of inclusion body proteins using a novel formulation.
Singhvi, Priyank; Saneja, Ankit; Ahuja, Rahul; Panda, Amulya K.
Afiliación
  • Singhvi P; Product Development Cell, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India. Electronic address: singhvipriyank177@gmail.com.
  • Saneja A; Formulation Laboratory, Dietetics & Nutrition Technology Division, CSIR - Institute of Himalayan Bioresource Technology, Palampur 176061, Himachal Pradesh, India.
  • Ahuja R; Product Development Cell, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India.
  • Panda AK; Product Development Cell, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India. Electronic address: amulya@nii.ac.in.
Int J Biol Macromol ; 193(Pt B): 2352-2364, 2021 Dec 15.
Article en En | MEDLINE | ID: mdl-34798190
Formation of protein aggregates as inclusion bodies (IBs) still poses a major hurdle in the recovery of bioactive proteins from E. coli. Despite the development of many mild solubilization buffers in last two decades, high-throughput recovery of functional protein from wide range of IBs is still a challenge at an academic and industrial scale. Herein, a novel formulation for improved recovery of bioactive protein from variety of bacterial IBs is developed. This novel formulation is comprised of 20% trifluoroethanol, 20% n-propanol and 2 M urea at pH 12.5 which disrupts the major dominant forces involved in protein aggregation. An extensive comparative study of novel formulation conducted on different IBs demonstrates its high solubilization and refolding efficiency. The overall yield of bioactive protein from human growth hormone expressed as bacterial IBs is reported to be around 50%. This is attributed to the capability of novel formulation to disrupt the tertiary structure of the protein while protecting the secondary structure of the protein, thereby reducing the formation of soluble aggregates during refolding. Thus, the formulation can eliminate the need of screening and optimizing various solubilization formulation and will improve the efficiency of recovering bioactive protein from variety of IB aggregates.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas / Cuerpos de Inclusión Límite: Humans Idioma: En Revista: Int J Biol Macromol Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas / Cuerpos de Inclusión Límite: Humans Idioma: En Revista: Int J Biol Macromol Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos